A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

NCT00374907 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Saxagliptin
DRUG: Placebo
DRUG: Metformin (blinded)
DRUG: Metformin (open-label)

Sponsor

AstraZeneca